Contact information Verified work emails, personal emails, and direct dials — unlocked in one click.
Work email
•••••@aevumed.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••
Free to start · No credit card required
Current company Aevumed, Inc
Medical Device · 12 employees · Malvern, Pennsylvania, United States
What is Aevumed? Aevumed is a medical device company dedicated to developing innovative orthopedic solutions for soft tissue repair and regeneration. At the core of its strategy is a patient-first approach that uniquely combines close collaboration with orthopedic surgeons and a proprietary, in-house developed AI system, AiTRIUM™, designed to tackle complex real-world clinical problems. This model ensures that product development begins with patient and surgeon needs, rather than market trends, enabling Aevumed to create minimally invasive implants and instruments that enhance healing, reduce recovery times, and improve long-term outcomes in tendon, ligament, and bone integration. By leveraging surgeon insight, AI-driven problem solving, advanced biomaterials, and 3D printing technologies, Aevumed is shaping the future of sports medicine and regenerative orthopedics with patient-focused innovation. Selected Surgery: What is rotator cuff surgery? The rotator cuff is a bundle of muscles and tendons that hold the humeral head (the ball of the shoulder) into the glenoid (the cup of the shoulder), and allow the upper arm to mobilize. Through aging and wear, these tendons can tear away from the bone, causing pain and mobility issues. Rotator cuff surgery aims at re-attaching these tendons to the bone. What is the market? The Global Orthopedic Device Market in 2024 is $45B. The Sports Medicine and Arthroscopic market is estimated at $12B and is the fastest growing (7.18% CAGR) in orthopedics. What are the clinical problems & needs? Each product tackles unique clinical problems. In rotator cuff, re-tears are the major complication after surgery accounting 20% – 90% retear rates and costing over $0.5B per year.